Novartis AG
XMUN:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
XMUN:NOT
|
CH |
|
E
|
Espey MFG and Electronics Corp
AMEX:ESP
|
US |
|
I
|
Intesa Sanpaolo SpA
DUS:IES
|
IT |
|
Pros Holdings Inc
NYSE:PRO
|
US |
|
Samsung Electronics Co Ltd
F:SSUN
|
KR |
|
C
|
Costco Wholesale Corp
XMUN:CTO
|
US |
|
Pierre et Vacances SA
PAR:VAC
|
FR |
|
A
|
Absolute Clean Energy PCL
SET:ACE
|
TH |
|
P
|
Prima Marine PCL
SET:PRM
|
TH |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 133.55 EUR with a low forecast of 102.29 EUR and a high forecast of 156.72 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
133.55
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 133.55 EUR with a low forecast of 102.29 EUR and a high forecast of 156.72 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
